The NeuroVista trial was a brain implant trial for treating epilepsy. Corporation was founded in 2002 by Dr. Leonidas Iasemidis and Dr. Daniel DiLorenzo as an early-stage medical device company that specialized in the management and treatment of epilepsy, including a novel Seizure Advisory System.[1][2][3][4]
Based in Seattle, Washington, NeuroVista was previously known as NeuroBionics Corporation,[5] and subsequently went through six rounds of financing totaling $61.3M USD.[6]
In 2010, Cyberonics announced that it had entered into technology agreements with NeuroVista.[7]
NeuroVista shut down operations in 2013.
15 participants[8]
References
edit- ^ Seattle 40 Under 40 - DiLorenzo's Early Tinkering leads to a Medical Device company
- ^ NeuroVista Publishes Study Results for their Implantable Seizure-Warning Device
- ^ NeuroVista’s Implantable EEG for Seizure Prediction
- ^ Form D filing with the U.S. Securities and Exchange Commission
- ^ BioNeuronics Founder (now NeuroVista)
- ^ VentureBeat on NeuroVista Founder & Financing
- ^ Cyberonics Announces Epilepsy Technology Agreements
- ^ Cook, Mark J.; O'Brien, Terence J.; Berkovic, Samuel F.; Murphy, Michael; Morokoff, Andrew; Fabinyi, Gavin; D'Souza, Wendyl; Yerra, Raju; Archer, John; Litewka, Lucas; Hosking, Sean (2013-06-01). "Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study". The Lancet Neurology. 12 (6): 563–571. doi:10.1016/S1474-4422(13)70075-9. ISSN 1474-4422.563-571&rft.date=2013-06-01&rft_id=info:doi/10.1016/S1474-4422(13)70075-9&rft.issn=1474-4422&rft.aulast=Cook&rft.aufirst=Mark J.&rft.au=O'Brien, Terence J.&rft.au=Berkovic, Samuel F.&rft.au=Murphy, Michael&rft.au=Morokoff, Andrew&rft.au=Fabinyi, Gavin&rft.au=D'Souza, Wendyl&rft.au=Yerra, Raju&rft.au=Archer, John&rft.au=Litewka, Lucas&rft.au=Hosking, Sean&rft_id=https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(13)70075-9/abstract&rfr_id=info:sid/en.wikipedia.org:User:Suriname0/NeuroVista trial" class="Z3988">
- ^ Kenneally, Christine (19 April 2021). "Do Brain Implants Change Your Identity?". The New Yorker. No. April 26 & May 3, 2021 Issue. Retrieved 17 September 2021.
- ^ Kwon, Diana (18 December 2020). "Forecasts of Epilepsy Seizures Could Become a Reality". Scientific American. Retrieved 17 September 2021.
- ^ Drew, Liam (21 July 2020). ""Like taking away a part of myself" ― life after a neural implant trial". Nature Medicine News Feature. No. 26. pp. 1154–1156. doi:10.1038/d41591-020-00028-8. Retrieved 17 September 2021.1154-1156&rft.date=2020-07-21&rft_id=info:doi/10.1038/d41591-020-00028-8&rft.aulast=Drew&rft.aufirst=Liam&rft_id=https://www.nature.com/articles/d41591-020-00028-8&rfr_id=info:sid/en.wikipedia.org:User:Suriname0/NeuroVista trial" class="Z3988">
Category:Medical technology companies of the United States Category:Manufacturing companies based in Seattle Category:Manufacturing companies established in 2002 Category:Technology companies established in 2002 Category:Manufacturing companies disestablished in 2013 Category:Technology companies disestablished in 2013